SCOTT SHIRLEY: Open Payments
NPI 1104554526 · FLEMING ISLAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,384 in 57 payments from 34 companies in 2025. Trend: 2023 $123 · 2024 $1,254 · 2025 $1,384
Food & beverage: $1,289Education: $95
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $119 |
| E.R. Squibb & Sons, L.L.C. | 1 | $115 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $102 |
| SEAGEN INC. | 1 | $95 |
| PFIZER INC. | 4 | $87 |
| Merck Sharp & Dohme LLC | 3 | $67 |
| Eisai Inc. | 3 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $59 |
| Pulmonx Corporation | 3 | $58 |
Products named: BREYANZI, Nubeqa, RYBREVANT, KEYTRUDA, Lenvima, XTANDI, CHARTIS CATHETER, ENHERTU.
Industry payments across FL — which companies pay providers there.
